In Vitro Diagnostics (IVD) is an enormous market and having comprehensive information on the state of IVD and its future is a vital part of making well-informed decisions. The 15th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights needed to understand the IVD market in its entirety. This 1,500+ page report is based on vendor reporting, interviews, vendor activities, and more on a global scale. Kalorama’s full assessment of the IVD diagnostic market makes The Worldwide Market for In Vitro Diagnostics Tests the most trusted report by top companies in the industry.

Why The Worldwide Market for In Vitro Diagnostic Tests?

Access the Most Comprehensive Report on the IVD Market
Gain Reliable Information from a Publication Focused Specifically on IVD Market Research
Better Navigate the IVD Market with this Report as Your Guide
Obtain Perspective and Data on Others in the IVD Industry
Learn Who is Tracking and Investing in the IVD Industry
Leverage Findings to Understand the Market on a Global Scale
Understand Market Data in the Context of Real-World Industry and Medical Practice Trends
Report Overview & Methodology

The Worldwide Market for In Vitro Diagnostic Tests is the result of months of analysis and review of secondary sources by seasoned analysts, critical readings of current and historic company filings and releases, interviews with relevant experts and searching of government sources and journal literature. All test segments contain valuable information on current market size and future projection. Compound annual growth rate is provided, as well as significant IVD companies in the market and IVD manufacturer’s product innovations. This detailed look at the IVD market yields unparalleled global market modeling.

This report gives you definitive answers to important questions like:

What is the Size of IVD Market Segments?
Who’s Winning?
Who’s Merged?
Who’s Launched Game-Changing Products?
What is the Competitive Landscape?
What are the Corporate Profiles of Companies in the Industry?
And more…
The most essential report on the IVD industry, The Worldwide Market for In Vitro Diagnostic Test, is a must-have tool for understanding the IVD market on a deeper level. Interested in learning more? Contact us today!

Country-Level Coverage
The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 14th Edition reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally. Trends in one part of the world affect IVD manufacturers’ product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included:

US
Germany
UK
France
Spain
Italy
Russia
Netherlands
Turkey
Poland
Canada
China
Japan
Malaysia
Singapore
South Korea
Australia
Saudi Arabia
Brazil
Argentina
Colombia
Chile
Peru
South Africa
Eastern Europe
Emerging Markets
Rest of World
The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the in vitro diagnostics industry as it is in 2022.

Competitive Analysis and Corporate Profiling
The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that Kalorama Information has in the in vitro diagnostic market is evident in its tiering and segmentation of companies. First tier, second-tier and specialist companies are profiled. Financial results, product launches, company history and strategic plans are analyzed in the profiles. Over 200 Profiles are included in the report.

Companies profiled include these, and many others:

Abbott Diagnostics
Accelerate Diagnostics, Inc.
Altona Diagnostics
Amoy Diagnostics Co. Ltd.
Angle
Arkray
ARUP Laboratories
Ascensia Diabetes Care Holdings AG
Beckman Coulter
Becton Dickinson (BD)
BGI Genomics (formerly Beijing Genome Institute)
Binding Site Group Ltd. (The)
Biocartis
Biocept, Inc.
Biohit
Biomerica Inc.
bioMerieux
Bio-Rad
BioReference Laboratories
Bio-Techne Corporation
Biotheranostics
Bruker
CareDx, Inc.
CellaVision AB
Cepheid
Cepheid / Danaher
Cerner Corp.
Copan
Corgenix Medical Corporation
Critical Diagnostics
Curetis
Cynvenio Biosystems (LungLife AI)
Dako A/S
Danaher
Dexcom Inc.
Diagnostica Stago, S.A.S.
DIAGON Kft. Hungary
DiaSorin
Edico Genome (Illumina)
Eiken Chemical Co., Ltd
EKF Diagnostics Holdings Plc
ELITech Group S.A.S.
Epic Sciences
Epigenomics AG
ERBA Diagnostics, Inc.
Fujirebio
Fujirebio Diagnostics, Inc.
Genomic Health (Exact Sciences)
Greiner Bio-One International GmbH
Grifols
Guardant Health, Inc.
Hain Lifescience GmbH
Hologic
Horiba Medical
HTG Molecular Diagnostics
Human Longevity Inc.
Illumina
Immucor
Immunodiagnostic Systems (IDS)
INOVA Diagnostics, Inc.
Instrumentation Laboratory
Lab Corp
Leica Biosystems
LifeScan Inc.
Luminex Corporation
Medica Corporation
MedTest DX
Menarini Diagnostics
Meridian Bioscience, Inc.
MilliporeSigma
Mindray
Nova Biomedical
Perkin Elmer
PerkinElmer, Inc. (PE)
Qiagen
Quest
Quest Diagnostics
Quidel Ortho
Radiometer
Randox
Randox Laboratories Ltd.
Rennova Health, Inc.
Response Biomedical Corp.
Roche Diagnostics
SD Biosensor
Seegene
Sekisui Diagnostics LLC
Shimadzu Scientific Instruments
Siemens Healthineers
Singulex, Inc.
Snibe Co. Ltd.
Sonic Healthcare
Sysmex
Tecan Group
Thermo Fisher Scientific
Tosoh Bioscience
Trinity Biotech Plc
Werfen